110 related articles for article (PubMed ID: 16540681)
1. An inducible mouse model of melanoma expressing a defined tumor antigen.
Huijbers IJ; Krimpenfort P; Chomez P; van der Valk MA; Song JY; Inderberg-Suso EM; Schmitt-Verhulst AM; Berns A; Van den Eynde BJ
Cancer Res; 2006 Mar; 66(6):3278-86. PubMed ID: 16540681
[TBL] [Abstract][Full Text] [Related]
2. Tumor-initiated inflammation overrides protective adaptive immunity in an induced melanoma model in mice.
Soudja SM; Wehbe M; Mas A; Chasson L; de Tenbossche CP; Huijbers I; Van den Eynde B; Schmitt-Verhulst AM
Cancer Res; 2010 May; 70(9):3515-25. PubMed ID: 20406967
[TBL] [Abstract][Full Text] [Related]
3. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous uveal amelanotic melanoma in transgenic Tyr-RAS+ Ink4a/Arf-/- mice.
Tolleson WH; Doss JC; Latendresse J; Warbritton AR; Melchior WB; Chin L; Dubielzig RR; Albert DM
Arch Ophthalmol; 2005 Aug; 123(8):1088-94. PubMed ID: 16087843
[TBL] [Abstract][Full Text] [Related]
5. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.
Ackermann J; Frutschi M; Kaloulis K; McKee T; Trumpp A; Beermann F
Cancer Res; 2005 May; 65(10):4005-11. PubMed ID: 15899789
[TBL] [Abstract][Full Text] [Related]
6. Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame.
Yang J; Luan J; Yu Y; Li C; DePinho RA; Chin L; Richmond A
Cancer Res; 2001 Nov; 61(22):8150-7. PubMed ID: 11719444
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
[TBL] [Abstract][Full Text] [Related]
9. Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines.
Melnikova VO; Bolshakov SV; Walker C; Ananthaswamy HN
Oncogene; 2004 Mar; 23(13):2347-56. PubMed ID: 14743208
[TBL] [Abstract][Full Text] [Related]
10. Array comparative genome hybridization for tumor classification and gene discovery in mouse models of malignant melanoma.
O'Hagan RC; Brennan CW; Strahs A; Zhang X; Kannan K; Donovan M; Cauwels C; Sharpless NE; Wong WH; Chin L
Cancer Res; 2003 Sep; 63(17):5352-6. PubMed ID: 14500367
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
[TBL] [Abstract][Full Text] [Related]
12. Minimal tolerance to a tumor antigen encoded by a cancer-germline gene.
Huijbers IJ; Soudja SM; Uyttenhove C; Buferne M; Inderberg-Suso EM; Colau D; Pilotte L; Powis de Tenbossche CG; Chomez P; Brasseur F; Schmitt-Verhulst AM; Van den Eynde BJ
J Immunol; 2012 Jan; 188(1):111-21. PubMed ID: 22140254
[TBL] [Abstract][Full Text] [Related]
13. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.
Sharpless NE; Kannan K; Xu J; Bosenberg MW; Chin L
Oncogene; 2003 Aug; 22(32):5055-9. PubMed ID: 12902988
[TBL] [Abstract][Full Text] [Related]
14. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
15. Genetic dissection of melanoma pathways in the mouse.
Yang FC; Merlino G; Chin L
Semin Cancer Biol; 2001 Jun; 11(3):261-8. PubMed ID: 11407950
[TBL] [Abstract][Full Text] [Related]
16. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
Krimpenfort P; Quon KC; Mooi WJ; Loonstra A; Berns A
Nature; 2001 Sep; 413(6851):83-6. PubMed ID: 11544530
[TBL] [Abstract][Full Text] [Related]
17. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
[TBL] [Abstract][Full Text] [Related]
18. Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo.
Sanchez-Perez L; Kottke T; Diaz RM; Ahmed A; Thompson J; Chong H; Melcher A; Holmen S; Daniels G; Vile RG
Cancer Res; 2005 Mar; 65(5):2009-17. PubMed ID: 15753401
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.
Prins RM; Odesa SK; Liau LM
Cancer Res; 2003 Dec; 63(23):8487-91. PubMed ID: 14679014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
